Urocortin 1 exhibits potent inhibition of cardiac sympathetic nerve activity in conscious sheep

Journal of Hypertension

Volumn 26, Issue 1, 2008, Pages 53-60

  Charles, Christopher J ^a   Jardine, David L ^a   Nicholls, M Gary ^a   Rademaker, Miriam T ^a   Richards, A Mark ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Arterial pressure; Cardiac output; Heart; Hormones; Sympathetic nervous system

Indexed keywords

CATECHOLAMINE; UROCORTIN I;

ANIMAL EXPERIMENT; ARTICLE; BOLUS INJECTION; CATECHOLAMINE BLOOD LEVEL; CONSCIOUSNESS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG MEGADOSE; DRUG POTENCY; HEART; HEART FUNCTION; HEART INNERVATION; HEART MUSCLE; HEART OUTPUT; HEART RATE; HEMODYNAMIC PARAMETERS; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; SHEEP; SYMPATHETIC NERVE; SYMPATHETIC TONE; VASCULAR RESISTANCE;

ANIMALS; ARTERIES; BLOOD PRESSURE; CARDIAC OUTPUT; CATECHOLAMINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HEART; HEART RATE; INJECTIONS, INTRAVENOUS; NEURAL INHIBITION; SHEEP; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; UROCORTINS; VASCULAR RESISTANCE; WAKEFULNESS;

EID: 37349023275     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282f01428     Document Type: Article

References (27)

1. Charles CJ, Rademaker MT, Richards AM. Urocortins: putative role in cardiovascular disease. Curr Med Chem: Cardiovasc Hematol Agents 2004; 2:43-47.
2. Parkes DG, Weisinger RS, May CN. Cardiovascular actions of CRH and urocortin: an update. Peptides 2001; 22:821-827.
3. Rademaker MT, Charles CJ, Espiner EA, Fisher S, Frampton CM, Kirkpatrick CMJ, et al. Beneficial hemodynamic, endocrine and renal effects of urocortin in experimental heart failure: Comparison with normal sheep. J Am Coll Cardiol 2002; 40:1495-1505.
4. Rademaker MT, Charles CJ, Espiner EA, Lainchbury JG, Richards AM. Four-day urocortin-1 administration has sustained beneficial hemodynamic, hormonal and renal effects in experimental heart failure. Eur Heart J 2005; 26:2055-2062.
5. Parkes D, May C. Cardiac and vascular actions of urocortin. In: Share L, editor. Hormones and the heart in health and disease. Totowa, New Jersey: Humana Press; 1999. pp. 39-52.
6. Jardine DL, Charles CJ, Melton IC, May CN, Forrester MDE, Bennett SI, et al. Continual recording of cardiac sympathetic nerve activity in conscious sheep. Am J Physiol 2002; 282:H93-H99.
7. Goldstein DS, Feuerstein G, Izzo JL, Kopin IJ, Keiser HR. Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sci 1981; 28:267-275.
8. Davis ME, Pemberton CJ, Yandle TG, Lainchbury JG, Rademaker MT, Nicholls MG, et al. Urocortin-1 infusion in normal humans. J Clin Endocrinol Metab 2004; 89:1402-1409.
9. Brown MR, Fisher LA, Spiess J, Rivier C, Rivier J, Vale W. Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism. Endocrinology 1982; 111:928-931.
10. Fisher LA, Jessen G, Brown MR. Corticotropin-releasing factor (CRF): mechanism to elevate mean arterial pressure and heart rate. Regul Pept 1983; 5:153-161.
11. Brown MR, Gray TS, Fisher LA. Corticotropin-releasing factor receptor antagonist: effects on the autonomic nervous system and cardiovascular function. Regul Pept 1986; 16:321-329.
12. Nijsen MJ, Croiset G, Stam R, Bruijnzeel A, Diamant M, de Wied D, et al. The role of CRH type 1 receptor in autonomic responses to corticotrophin-releasing hormone in the rat. Neuropsychopharmacol 2000; 22:388-399.
13. Yokotani K, Murakami Y, Okada S, Hirata M. Role of brain arachidonic acid cascade on central CRF1 receptor-mediated activation of sympathoadrenomedullary outflow in rats. Eur Pharmacol 2001; 419:183-189.
14. Chu CP, Qiu DL, Kato K, Kunitake T, Watanabe S, Yu NS, et al. Central stresscopin modulates cardiovascular function through the adrenal medulla in conscious rats. Regul Pept 2004; 119:53-59.
15. 2 in the brain on splenic sympathetic nerve activity in rats. J Auton Nerv Syst 1997; 67:200-206.
16. Kurosawa M, Sato A, Swenson RS, Takahashi Y. Sympatho-adrenal medullary functions in response to intracerebroventricularly injected corticotrophin- releasing factor in anesthetised rats. Brain Res 1986; 367:250-257.
17. Egawa M, Yoshimatsu H, Bray GA. Preoptic area injection of corticotrophin-releasing hormone stimulates sympathetic activity. Am J Physiol 1990; 259:R799-R806.
18. Ninomiya I, Nisimaru N, Irisawa H. Sympathetic nerve activity to spleen, kidney and heart in response to baroreceptor input. Am J Physiol 1971; 221:1346-1351.
19. Pagani M, Schwartz PJ, Banks R, Lombardi F, Malliani A. Reflex responses to sympathetic preganglionic neurones initiated by different cardiovascular receptors in spinal animals. Brain Res 1974; 68:215-225.
20. De Fanti BA, Martinez JA. Central urocortin activation of sympathetic-regulated energy metabolism in Wistar rats. Brain Res 2002; 930:37-41.
21. Saper CB, Loewy AD, Swanson LW, Cowan WM. Direct hypothalamo-autonomic connections. Brain Res 1976; 117:305-312.
22. Koob GF, Heinrichs SC. A role for corticotrophin releasing factor and urocortin in behavioural responses to stressors. Brain Res 1999; 848:141-152.
23. Ng LL, Loke IW, O'Brien RJ, Squire IB, Davies JE. Plasma urocortin in human systolic heart failure. Clin Sci 2004; 106:383-388.
24. Parkes D, Vaughan J, Rivier J, Vale W, May CN. Cardiac inotropic actions of urocortin in conscious sheep. Am J Physiol Heart Circ Physiol 1997; 272:H2115-H2122.
25. Gardiner SM, March JE, Kemp PA, Bennett T. A comparison between cardiovascular actions of urocortin 1 and urocortin 2 (stresscopin-related peptide) in conscious rats. J Pharmacol Exp Ther 2007; 321:221-226.
26. Brar BK, Jonassen AK, Stephanou A, Santilli G, Railson J, Knight RA, et al. Urocortin protects against ischemic and reperfusion injury via MAPK-dependent pathway. J Biol Chem 2000; 275:8505-8514.
27. Schulman D, Latchman DS, Yellon DM. Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. Am J Physiol 2002; 283:H1481-H1488.